- Home
- GDTC vs GROW Comparison
GDTC vs GROW Comparison
Compare GDTC & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- GROW
- Stock Information
- Founded
- GDTC 2018
- GROW 1968
- Country
- GDTC Singapore
- GROW United States
- Employees
- GDTC N/A
- GROW N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- GROW Investment Managers
- Sector
- GDTC Health Care
- GROW Finance
- Exchange
- GDTC Nasdaq
- GROW Nasdaq
- Market Cap
- GDTC 28.0M
- GROW 31.8M
- IPO Year
- GDTC 2023
- GROW N/A
- Fundamental
- Price
- GDTC $1.86
- GROW $2.49
- Analyst Decision
- GDTC Buy
- GROW
- Analyst Count
- GDTC 1
- GROW 0
- Target Price
- GDTC $5.00
- GROW N/A
- AVG Volume (30 Days)
- GDTC 10.3K
- GROW 41.4K
- Earning Date
- GDTC 01-01-0001
- GROW 09-09-2025
- Dividend Yield
- GDTC N/A
- GROW 3.63%
- EPS Growth
- GDTC N/A
- GROW N/A
- EPS
- GDTC N/A
- GROW 0.01
- Revenue
- GDTC $368,838.00
- GROW $8,932,000.00
- Revenue This Year
- GDTC $5.37
- GROW N/A
- Revenue Next Year
- GDTC N/A
- GROW N/A
- P/E Ratio
- GDTC N/A
- GROW $237.15
- Revenue Growth
- GDTC N/A
- GROW N/A
- 52 Week Low
- GDTC $1.20
- GROW $2.02
- 52 Week High
- GDTC $4.05
- GROW $2.73
- Technical
- Relative Strength Index (RSI)
- GDTC 41.07
- GROW 59.16
- Support Level
- GDTC $1.96
- GROW $2.35
- Resistance Level
- GDTC $2.26
- GROW $2.58
- Average True Range (ATR)
- GDTC 0.10
- GROW 0.09
- MACD
- GDTC -0.02
- GROW -0.00
- Stochastic Oscillator
- GDTC 17.95
- GROW 45.45
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.